CD13 is a therapeutic target in human liver cancer stem cells.
Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard GF, Doki Y, Mori M.
Haraguchi N, et al.
J Clin Invest. 2010 Sep;120(9):3326-39. doi: 10.1172/JCI42550. Epub 2010 Aug 9.
J Clin Invest. 2010.
PMID: 20697159
Free PMC article.